Submissions from 2021
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies, Aasems Jacob, Rishi Raj, Derek B. Allison, and Zin W. Myint
A Case Report of Metastatic Castration-Resistant Prostate Cancer Harboring a PTEN Loss, Zin W. Myint, Derek B. Allison, and Carleton S. Ellis
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters, Zin W. Myint, Ramon C. Sun, Patrick J. Hensley, Andrew C. James, Peng Wang, Stephen E. Strup, Robert J. McDonald, Donglin Yan, William H. St. Clair, and Derek B. Allison
Submissions from 2018
Profiling Prostate Cancer Therapeutic Resistance, Cameron A. Wade and Natasha Kyprianou
Submissions from 2017
Reversion of Epithelial-Mesenchymal Transition by a Novel Agent DZ-50 via IGF Binding Protein-3 in Prostate Cancer Cells, Zheng Cao, Shahriar Koochekpour, Stephen E. Strup, and Natasha Kyprianou
Primary Upper Urinary Tract Small Cell Carcinoma: A Case Series and Literature Review, Patrick J. Hensley, Amul A. Bhalodi, and Shubham Gupta
Nuclear Spindles Pave the Way to Metastasis, Patrick J. Hensley and Natasha Kyprianou
Open Vesicocalicostomy for the Management of Transplant Ureteral Stricture, Margaret M. Higgins, Jonathan P. Walker, Michael F. Daily, and Shubham Gupta
Mechanisms of Therapeutic Resistance in Prostate Cancer, Mary Nakazawa, Channing Paller, and Natasha Kyprianou
Submissions from 2016
Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer Following Primary Brachytherapy, John M. Lacy, William A. Wilson, Raevti Bole, Li Chen, Ali S. Meigooni, Randall G. Rowland, and William H. St. Clair
Submissions from 2015
An Ex Vivo Approach to Complex Renal Artery Aneurysm Repair, Noah T. Scherrer, Roberto Gedaly, Ramakrishna Venkatesh, Michael A. Winkler, and Eleftherios S. Xenos
CD151-α3β1 Integrin Complexes are Prognostic Markers of Glioblastoma and Cooperate with EGFR to Drive Tumor Cell Motility and Invasion, Pengcheng Zhou, Sonia Erfani, Zeyi Liu, Changhe Jia, Yecang Chen, Bingwei Xu, Xinyu Deng, Jose E. Alfáro, Li Chen, Dana L. Napier, Michael Lu, Jian-An Huang, Chunming Liu, Olivier Thibault, Rosalind Segal, Binhua P. Zhou, Natasha Kyprianou, Craig Horbinski, and Xiuwei H. Yang
Submissions from 2014
A Tale of Two Trials: The Impact of 5α-Reductase Inhibition on Prostate Cancer (Review), John M. Lacy and Natasha Kyprianou
The Promise of Novel Molecular Markers in Bladder Cancer, Jahan Miremami and Natasha Kyprianou
